Lawsuit Investigation for Patients Denied Coverage for Hepatitis C Drug Harvoni

Last Updated on September 24, 2021

Comments |

At A Glance

This Alert Affects:
People who weren’t covered by their health insurance for the cost of Harvoni, the first known drug to cure hepatitis C.
What’s Going On?
Attorneys working with are investigating whether some health insurance companies are wrongfully denying coverage for Harvoni for early-stage hepatitis C in an attempt to save money at the expense of patients’ health. It's possible that class action lawsuits could be filed to help patients get the coverage they deserve.
How Could a Class Action Help?
A successful case could order insurance companies to change the way they handle coverage for hepatitis treatment and help recover money for patients whose insurers didn’t cover their prescriptions.
What You Can Do
If you were denied coverage for your Harvoni prescription, fill out the form on this page. One of the attorneys handling this investigation may then reach out to you directly to explain more about your rights and why you may be owed money from your health insurer.

The information submitted on this page will be forwarded to Greg Coleman Law who has sponsored this investigation.

Contact Us